News blog


  • BY: Andrew Hore |
  • POSTED: 07/01/2010 |

Syntopix Group says that it plans a fundraising this year.

The skin treatments developer had £894,000 in the bank at the end of July 2009. There was a cash outflow from operations of £1.05m during the financial year.

Syntopix has identified two potential treatments for acne and it needs the extra cash to turn these into potential products.

Syntopix has signed a joint development agreement with Procter & Gamble, which wants to use Syntopix’s antimicrobial technology to enhance one of its existing products. There is no news about this collaboration. 

Revenues improved from £141,000 to £190,000 in the year to July 2009.

During 2008, Syntopix raised £1.48m at 75p a share.

At 77p a share, Syntopix is valued at £5.98m. 

© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds